 Carcinoma in Situ
"Carcinoma in Situ" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Descriptor ID |
D002278
|
| MeSH Number(s) |
C04.557.470.200.240
|
| Concept/Terms |
Carcinoma in Situ- Carcinoma in Situ
- Carcinoma, Preinvasive
- Preinvasive Carcinoma
- Carcinoma, Intraepithelial
- Intraepithelial Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma in Situ".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma in Situ".
This graph shows the total number of publications written about "Carcinoma in Situ" by people in UAMS Profiles by year, and whether "Carcinoma in Situ" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2022 | 3 | 0 | 3 | | 2021 | 1 | 0 | 1 | | 2020 | 3 | 1 | 4 | | 2019 | 0 | 1 | 1 | | 2016 | 0 | 2 | 2 | | 2015 | 3 | 0 | 3 | | 2014 | 3 | 0 | 3 | | 2013 | 3 | 1 | 4 | | 2012 | 2 | 0 | 2 | | 2011 | 4 | 0 | 4 | | 2010 | 3 | 0 | 3 | | 2008 | 2 | 1 | 3 | | 2007 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2005 | 2 | 1 | 3 | | 2004 | 0 | 3 | 3 | | 2003 | 1 | 1 | 2 | | 2002 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2000 | 1 | 1 | 2 | | 1999 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1994 | 2 | 0 | 2 | | 1992 | 1 | 1 | 2 | | 1990 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma in Situ" by people in Profiles over the past ten years.
-
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86.
-
Hamza MA, Quick CM, Williams HR, Patil NM, Shalin SC. HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases. Int J Gynecol Pathol. 2023 Jul 01; 42(4):338-346.
-
Hong MJ, Lum SS, Dupont E, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, Fenton A, Murray M, Solomon NL, Ollila DW, Lazar M, Namm JP, Walters LL, Chagpar AB. Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care. J Surg Res. 2022 11; 279:393-397.
-
Barron CR, Paczos TA, Varghese S, Smoller BR. Acantholytic Squamous Cell Carcinoma Arising From Lichen Sclerosus: A Rare Case Affecting Vulvar Skin. Int J Gynecol Pathol. 2022 Mar 01; 41(2):122-125.
-
Wright MF, Fitzlaff S, Wyeth A, Zaragoza-Watkins M, Podoll MB, Quick CM, Watkins JC. Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy. Int J Gynecol Pathol. 2021 May 01; 40(3):240-247.
-
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117.
-
Hajiran A, Zemp L, Aydin AM, Cheryian SK, Pow-Sang JM, Chahoud J, Spiess PE. Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. Urol Oncol. 2021 01; 39(1):72.e1-72.e5.
-
Lee MS, Shen M, Williams A, Kendrick D, Weizer A, Montgomery J. Retroureteral Small Bowel Herniation Resulting in Bowel Obstruction Following Robotic Cystectomy With Extracorporeal Ileal Conduit. Urology. 2021 01; 147:3-6.
-
Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL, Wethington SL, Levinson K, Grumbine F, Ferriss JS, Tanner EJ, Fader AN. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecol Oncol. 2020 05; 157(2):348-356.
-
Mallinger WD, Quick CM. Benign and Premalignant Lesions of the Endometrium. Surg Pathol Clin. 2019 Jun; 12(2):315-328.
-
Klimberg VS. Data on Ductal Carcinoma In Situ Encumbered by Opinion. Oncology (Williston Park). 2016 09 15; 30(9):832-3.
-
Bhasin MK, Ndebele K, Bucur O, Yee EU, Otu HH, Plati J, Bullock A, Gu X, Castan E, Zhang P, Najarian R, Muraru MS, Miksad R, Khosravi-Far R, Libermann TA. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Oncotarget. 2016 Apr 26; 7(17):23263-81.
-
Erdem H, Gundogdu B, Ankarali H, Yasar M, Sener E, Oktay M, Bahadir A, Uzunlar AK, Gursan N, Ozaydin I, Sahiner C. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms. Niger J Clin Pract. 2015 Sep-Oct; 18(5):638-43.
-
Shafirstein G, Rigual NR, Arshad H, Cooper MT, Bellnier DA, Wilding G, Tan W, Merzianu M, Henderson BW. Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib study. Head Neck. 2016 04; 38 Suppl 1:E377-83.
-
Joiner AK, Quick CM, Jeffus SK. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems. Int J Gynecol Pathol. 2015 Jan; 34(1):40-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|